Business description: Zai Lab Limited

Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.

Number of employees: 1,784

Sales by Activity: Zai Lab Limited

Fiscal Period: December 2021 (USD) 2022 (USD) 2023 (USD) 2024 (USD) 2025 (USD)

Biotechnology

144M 215M 267M 399M 460M

Geographical breakdown of sales: Zai Lab Limited

Fiscal Period: December 2021 (USD) 2022 (USD) 2023 (USD) 2024 (USD) 2025 (USD)

People's Republic of China (PRC)

144M - - 399M 460M

Executive Committee: Zai Lab Limited

Manager TitleAgeSince
Chief Executive Officer 61 01/04/2014
Director of Finance/CFO 58 07/07/2023
President 62 01/12/2022
President 56 01/04/2023
Chief Tech/Sci/R&D Officer - 01/09/2023

Composition of the Board of Directors: Zai Lab Limited

Director TitleAgeSince
Chairman 61 01/04/2014
Director/Board Member 83 01/01/2017
Director/Board Member 75 01/01/2017
Director/Board Member 61 01/10/2018
Director/Board Member 68 01/01/2019
Director/Board Member 68 13/10/2021
Director/Board Member 76 19/11/2021
Director/Board Member 55 01/08/2014
Director/Board Member 64 07/01/2023

Shareholders: Zai Lab Limited

NameStocks%Valuation
RTW Investments LP
9.685 %
12,117,985 9.685 % 267 M $
RTW Investments LP
5.254 %
6,574,032 5.254 % 145 M $
TCG Crossover Management LLC
4.905 %
6,137,627 4.905 % 135 M $
TCG Crossover Management LLC
4.905 %
6,137,627 4.905 % 135 M $
RA Capital Management LP
4.59 %
5,743,533 4.59 % 127 M $
NameStocks%Valuation
Qiming Venture Partners Ltd.
3.907 %
48,883,643 3.907 % 108 M $
Wellington Management Co. LLP
3.845 %
48,112,590 3.845 % 107 M $
Jupiter Topco LLC
3.157 %
39,501,040 3.157 % 87 M $
Goldman Sachs & Co. LLC (Private Banking)
2.685 %
33,599,835 2.685 % 74 M $
1.559 %
19,508,280 1.559 % 43 M $

Company details: Zai Lab Limited

Zai Lab Ltd.

899 Halei Road

201203, Shanghai

+86 21 6163 2588

http://www.zailaboratory.com
address Zai Lab Limited(ZLAB)

Biopharmaceuticals

Change 5-day change 1-year change 3-year change Capi.($)
-5.53%-3.45%+13.10%-11.13% 2.77B
+1.26%+6.61%+40.79%+145.27% 1,286B
+0.79%+3.45%+45.84%+92.04% 688B
+0.20%+1.28%+26.97%+114.41% 521B
-0.44%+3.69%+41.45%+70.04% 386B
+0.55%+0.70%+59.02%+45.79% 364B
-0.12%+0.74%+28.39%+60.32% 302B
+0.37%+0.37%+3.33%+38.57% 287B
-0.30%+1.14%+38.29%+70.56% 252B
+0.08%+0.71%+34.44%+123.99% 208B
Average -0.31%+1.52%+33.16%+74.99% 430B
Weighted average by Cap. +0.53%+3.25%+37.68%+99.21%
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - Zai Lab Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
24.60USD
Average target price
34.12USD
Spread / Average Target
+38.72%
  1. Stock Market
  2. Stocks
  3. ZLAB Stock
  4. Company Zai Lab Limited